Structures by: Gryl M.
Total: 30
5,6,10b-triazaacephenanthrylene
C26H15N5O
The journal of physical chemistry. A (2020)
a=9.2313(1)Å b=9.3742(1)Å c=11.8955(1)Å
α=84.254(1)° β=67.426(1)° γ=81.238(1)°
Tyraminium violurate
C4H2N3O4,C8H12NO
IUCrJ (2019) 6, 2
a=6.8711(13)Å b=15.119(2)Å c=11.884(2)Å
α=90° β=91.858(16)° γ=90°
Tyraminium violurate monohydrate
C4H2N3O4,C8H12NO,H2O
IUCrJ (2019) 6, 2
a=14.0525(3)Å b=7.81340(10)Å c=12.8242(2)Å
α=90° β=91.848(2)° γ=90°
Tyraminium violurate
C12H14N4O5
IUCrJ (2019) 6, 2
a=13.2706(12)Å b=7.6510(3)Å c=13.1269(9)Å
α=90° β=102.097(8)° γ=90°
5,6,10b-triazaacephenanthrylene
C26H15N5O
IUCrJ (2018) 5, 3
a=9.3241(8)Å b=9.5329(8)Å c=12.0593(14)Å
α=83.218(8)° β=66.653(7)° γ=80.098(7)°
5,6,10b-triazaacephenanthrylene
C26H15N5O
IUCrJ (2018) 5, 3
a=9.2504(5)Å b=9.4009(8)Å c=11.9245(6)Å
α=84.147(6)° β=67.347(5)° γ=81.113(6)°
Melamine barbital addition compound
C8H12N2O3,C3H6N6
The Journal of Physical Chemistry C (2015) 119, 1 590
a=9.5289(3)Å b=9.1191(3)Å c=8.6670(2)Å
α=90° β=90° γ=90°
Sulfanilamide (4-sulfamoyl-phenyl)oxalamic acid salt
C8H7N2O5S,C6H9N2O2S
CrystEngComm (2018) 20, 26 3638
a=17.2685(4)Å b=6.2883(2)Å c=7.9171(2)Å
α=90° β=97.627(3)° γ=90°
Sulfanilamid sulfamic acid salt
C6H9N2O2S,H2NO3S
CrystEngComm (2018) 20, 26 3638
a=4.81720(10)Å b=9.6864(3)Å c=11.2302(3)Å
α=90° β=96.724(3)° γ=90°
Melamine barbital addition compound
C8H12N2O3,C3H6N6
CrystEngComm (2014) 16, 26 5765
a=9.5289(3)Å b=9.1191(3)Å c=8.6670(2)Å
α=90° β=90° γ=90°
Complex of Zn-acetate with (E)-3-{[2-(2-aminoethyl)pyridine]- phenylmethylidene}-1,4-dihydro-2H-1-phenylpyrrolo[2,3-b]quinoxalin- 2-one and acetonitrile solvent molecules in the ratio 1:1:1
C32H25N5O3Zn1.C2H3N1
CrystEngComm (2015) 17, 3 498
a=13.78516(8)Å b=14.11066(8)Å c=15.45815(9)Å
α=90.00° β=101.3577(5)° γ=90.00°
(E)-3-{[2-(2-aminoethyl)pyridine]-phenylmethylidene}-1,4-dihydro-2H-1- phenylpyrrolo[2,3-b]quinoxalin-2-one; non centrosymmetric structure containing the molecules with (pR):(pS) configuration ratio = 0.828:0.172
C30H24.32N5O1.66
CrystEngComm (2015) 17, 3 498
a=5.75094(3)Å b=17.80093(8)Å c=11.63481(6)Å
α=90.00° β=98.7275(5)° γ=90.00°
(E)-3-{[2-(2-aminoethyl)pyridine]-phenylmethylidene}-1,4-dihydro-2H-1- phenylpyrrolo[2,3-b]quinoxalin-2-one, racemate of two symmetrically independent conformers
C30H23N5O
CrystEngComm (2015) 17, 3 498
a=12.65632(9)Å b=19.63117(11)Å c=19.20284(11)Å
α=90.00° β=97.3451(6)° γ=90.00°
2-((2,6-dimethylphenyl)amino)-N,N-dimethyl-2-oxoethanaminium 2,4,6-trioxohexahydropyrimidin-5-ide
C14H23N2OC4H3N2O3
CrystEngComm (2013) 15, 17 3275
a=11.1440(2)Å b=11.4500(2)Å c=14.8721(3)Å
α=90.00° β=92.6884(11)° γ=90.00°
Barbituric acid urea addition compound
C4H4N2O3,CH4N2O
Acta Crystallographica Section B (2011) 67, 2 144-154
a=7.8123(1)Å b=6.9384(1)Å c=14.1179(3)Å
α=90° β=96.727(1)° γ=90°
Barbituric acid urea addition compound
C4H4N2O3,CH4N2O
Acta Crystallographica Section B (2011) 67, 2 144-154
a=16.0474(5)Å b=5.0280(2)Å c=10.3879(3)Å
α=90° β=110.093(2)° γ=90°
C4H6N3O,C4H4N2O3,C4H5N3O,C4H3N2O3,2(H2O)
C4H6N3O,C4H4N2O3,C4H5N3O,C4H3N2O3,2(H2O)
Acta Crystallographica Section B (2019) 75, 1
a=6.7486(3)Å b=10.5419(4)Å c=15.6580(7)Å
α=81.293(3)° β=79.732(2)° γ=79.974(3)°
2-(Diethylamino)-N-(2,6-dimethylphenyl)-acetamide
C14H22N2O
Acta Crystallographica Section B (2015) 71, 4 392-405
a=12.86660(10)Å b=13.69660(10)Å c=16.20490(10)Å
α=90° β=100.6860(10)° γ=90°
Barbituric acid urea addition compound
C4H4N2O3,CH4N2O
Acta Crystallographica Section B (2008) 64, 5 623-632
a=7.8857(3)Å b=6.9620(2)Å c=14.4283(6)Å
α=90.00° β=98.0270(10)° γ=90.00°
Barbituric acid urea addition compound
C4H4N2O3,CH4N2O
Acta Crystallographica Section B (2008) 64, 5 623-632
a=8.1588(4)Å b=9.1117(4)Å c=10.9268(5)Å
α=100.248(2)° β=91.515(2)° γ=99.192(2)°
Barbituric acid urea addition compound
C4H4N2O3,CH4N2O
Acta Crystallographica Section B (2008) 64, 5 623-632
a=15.9423(7)Å b=5.0984(3)Å c=10.5534(5)Å
α=90.00° β=110.570(2)° γ=90.00°
Rubidium 2,4,6-trioxo-1,3-diazinan-5-ide--1,3-diazinane-2,4,6-trione--water (1/1/1)
Rb,C4H4N2O3,C4H5N2O3,H2O1
Acta Crystallographica Section E (2011) 67, 5 m571-m572
a=9.88100(10)Å b=19.6790(5)Å c=6.4530(3)Å
α=90.00° β=108.26(2)° γ=90°
<i>N</i>-(5-Nitropyridin-2-yl)-5<i>H</i>- dibenzo[<i>d</i>,<i>f</i>][1,3]diazepine-6-carboxamide
C19H13N5O3
Acta Crystallographica Section E (2011) 67, 6 o1507
a=12.9702(2)Å b=9.21040(10)Å c=13.4145(2)Å
α=90.000° β=100.6920(10)° γ=90.000°
Oxalic acid urea addition compound
C2H2O4,2(CH4N2O)
Crystal Growth & Design (2015) 15, 11 5578
a=5.0451(1)Å b=12.3754(2)Å c=6.8563(1)Å
α=90° β=96.289(1)° γ=90°
(S)-(-)-malic acid urea addition compound
C4H6O5,CH4N2O
Crystal Growth & Design (2015) 15, 11 5578
a=6.6411(2)Å b=6.9162(2)Å c=9.0495(2)Å
α=90.00° β=94.697(1)° γ=90.00°
C8H11N3O6
C8H11N3O6
Crystal Growth & Design (2013) 13, 7 2995
a=5.52370(10)Å b=6.7090(2)Å c=26.8532(5)Å
α=90.00° β=90.00° γ=90.00°
C8H11N3O6
C8H11N3O6
Crystal Growth & Design (2013) 13, 7 2995
a=6.6800(2)Å b=9.2116(2)Å c=16.3534(4)Å
α=90° β=90° γ=90°
(E)-3-[(pyridin-2-ylamino)phenylmethylidene]-1,3-dihydro-2H- 1-phenylpyrrolo[2,3-b]quinoxalin-2-one
C28H19N5O
Inorganic chemistry (2015) 54, 17 8423-8435
a=11.2768(7)Å b=6.4518(3)Å c=15.1230(7)Å
α=90.00° β=105.614(6)° γ=90.00°
(Z)-3-[(pyridin-2-ylamino)phenylmethylidene]-1,3-dihydro-2H- 1-phenylpyrrolo[2,3-b]quinoxalin-2-one
C28H19N5O
Inorganic chemistry (2015) 54, 17 8423-8435
a=11.6851(2)Å b=11.2288(2)Å c=16.2568(2)Å
α=90.00° β=99.620(2)° γ=90.00°
(E)-3-[(pyridin-2-ylamino)phenylmethylidene]-1,3-dihydro-2H- 1-phenylpyrrolo[2,3-b]quinoxalin-2-one with Zn(II) 2:1 copmplex and 0.90 methanol
(C56H36N10O2Zn).(C1.80H7.20O1.80)
Inorganic chemistry (2015) 54, 17 8423-8435
a=18.6633(1)Å b=14.0837(1)Å c=18.5416(1)Å
α=90.00° β=93.0418(5)° γ=90.00°